/stocks — the workspaceLOADING
All TMDXSEC filings, by type → · Earnings date & implied move · Search inside filings
TransMedics Group, Inc. (TMDX) is a electromedical & electrotherapeutic apparatus company. Piotroski F-Score 7/8. 12 insider Form 4 filings in the last 90 days. Next earnings projected around 2026-10-28 from TMDX's year-over-year reporting pattern (not yet company-confirmed). Fundamentals from SEC filings; prices are end-of-day.
What’s behind TMDX’s latest move — the size, how unusual the volume is, and the catalyst on the tape, explained and cited to the source.
EOD daily bars · delayed, not real-time · data: DatabentoCharting by TradingView Lightweight Charts™
FY ending 2025-12-31 vs 2024-12-31. original 1968 formula; calibrated on manufacturers, read financials/REITs with care
eight-variable model; a screen for earnings-quality review, not an accusation
Estimates, not targets. The DCF treats free cash flow as cash flow to equity and divides by shares (the common retail shortcut — it skips net debt and a full WACC), so it’s a sanity-check, not a valuation opinion. All inputs are from TMDX’s SEC filings; change any assumption above and the numbers update live. Educational only — not investment advice.
A plain-English read on TMDX plus an auto-SWOT — built from TMDX's SEC filings and market data, every point cited, nothing invented. Educational, not investment advice.
Four AI analysts — a bull, a bear, a risk manager, and a PM — debate TMDX using only the SEC-filing and market facts below. Every point cites its evidence; nothing is invented. This is educational research, not investment advice.
Educational only — not financial advice. Data from SEC EDGAR public filings; no live market data is shown. Figures reflect the company's own reported XBRL facts and may lag.
XBRL company facts, SEC EDGAR. TTM = last four reported quarters. Valuation ratios arrive with a price source — we don't fake quotes.
Has TMDX been issuing shares? Offering history →
↓ Download the fiscal-year statement table (XLSX) · revenue, income, EPS, cash flow, balance sheet · from SEC XBRL, dated
No tracked institution reported a position in TMDX in the latest 13F round.
No lawmaker has disclosed a trade in TMDX under the STOCK Act.
Every figure is from TMDX’s SEC cash-flow statement. This describes how management deployed cash last period — it is not a grade of that deployment, not a forecast, and not investment advice. Whether reinvesting, paying down debt, or returning cash was the right call depends on the return each earns, which the filings do not settle. Educational information only.
Projected from TMDX's own SEC 8-K filing history — the year-over-year reporting pattern (about 47% land the exact day, about 91% within a week, measured across 4,713 past reports). No analyst estimates and nothing invented, and every confirmed date links to the source it came from, so you can check it yourself. It upgrades the momentTMDX files or announces.
TMDX has rallied after 5 of its last 8 earnings reports.
Each figure is one earnings reaction — how much TMDX moved from the closing price the day before a report to the close the day after. Based on its last 8 reports.
Large earnings reactions have been common.
TMDX has traded higher after most recent earnings releases.
The average is inflated by its most volatile prints (+16.4% and -29.3%).
A more typical earnings reaction has been approximately ±11.4%.
Realized close-to-close history only — no options-implied move, no analyst estimates.
| Reported | Close-to-close |
|---|---|
| 2026-08-04 | -6.2% |
| 2026-05-05 | -24.9% |
| 2026-02-27 | +9.2% |
| 2025-10-29 | +4.7% |
| 2025-07-30 | +13.5% |
| 2025-05-08 | +16.4% |
| 2025-02-27 |
Earnings dates are the company's 8-K Item 2.02 filings (SEC). Reactions from Databento EOD.
| +3.5% |
| 2024-10-28 | -29.3% |
| Gunderson Thomas J.Director | SELL | $722K | view → |
| Weill DavidDirector | SELL | $524K | view → |
| Lovell StephanieDirector | SELL | $178K | view → |
| Corcoran NicholasSee remarks | SELL | $413K | view → |
| Ranganath Anil P.See remarks | SELL | $120K | view → |
| Hernandez GerardoChief Financial Officer | SELL | $1.1M | view → |
These two signals are 15 days apart. Form 4 is filed within two business days of the trade; 13F is filed up to 45 days after quarter end and describes positions as they stood on that date. Agreement between them is not confirmation — the funds may have moved months before the insiders did, or the other way round. Read them as two separate observations that happen to point the same way, never as one signal backing up another.
From SEC Form 4 and 13F filings. Both are backward-looking disclosures on different reporting clocks, and neither predicts price. Educational information only — not investment advice.